Literature DB >> 7774059

Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome.

T J Neuhaus1, M Wadhwa, R Callard, T M Barratt.   

Abstract

We investigated the production of cytokines by peripheral blood mononuclear cells (PBMC) and serum cytokine concentrations in children with steroid-sensitive idiopathic nephrotic syndrome (SSNS). PBMC from patients off treatment were collected during remission and relapse and cultured in medium alone or stimulated with calcium ionophore plus phorbol myristate acetate. Control PBMC were taken from healthy age-matched children. IL-2 was measured by bioassay, IL-4 by immunoradiometric assay, and IL-8 and IFN-gamma by ELISA. After 24 h culture without stimulation, IL-2, IL-4 and IFN-gamma were not detectable in the supernatant in any of the children. After stimulation, the supernatant concentrations of IL-2 (median 172 U/ml at 24 h) and IL-4 (160 pg/ml at 24 h; 210 pg/ml at 72 h) were significantly increased in relapse compared with remission (IL-2 37 U/ml; IL-4 65 pg/ml and 60 pg/ml) and controls (IL-2 69 U/ml; IL-4 40 pg/ml and 40 pg/ml) (P < 0.05). The concentration of IFN-gamma was not significantly increased in relapse compared with remission and controls (600, 325, and 145 U/ml, respectively, at 72 h). IL-8 concentrations were similar in relapse, remission and controls with stimulation (median 32, 40 and 40 ng/ml, respectively) and without (30, 17 and 10 ng/ml). IL-2 was not detectable in serum, but IL-4, IL-8 and IFN-gamma were measurable in about half the patients, both in relapse and remission, though were virtually undetectable in controls. We conclude that relapse of SSNS in children is associated with T lymphocyte activation with release of IL-2, IL-4 and IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774059      PMCID: PMC1534457          DOI: 10.1111/j.1365-2249.1995.tb03725.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

Review 1.  Regulation of IgE synthesis in humans.

Authors:  D Vercelli; R S Geha
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

2.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

Authors:  J M Schröder; U Mrowietz; E Morita; E Christophers
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

3.  Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome.

Authors:  N Yoshizawa; Y Kusumi; K Matsumoto; S Oshima; A Takeuchi; O Kawamura; T Kubota; S Kondo; H Niwa
Journal:  Nephron       Date:  1989       Impact factor: 2.847

4.  Effect of supernatants derived from T lymphocyte culture in minimal change nephrotic syndrome on rat kidney capillaries.

Authors:  K Maruyama; S Tomizawa; N Shimabukuro; T Fukuda; T Johshita; T Kuroume
Journal:  Nephron       Date:  1989       Impact factor: 2.847

5.  Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones.

Authors:  X Paliard; R de Waal Malefijt; H Yssel; D Blanchard; I Chrétien; J Abrams; J de Vries; H Spits
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

6.  Serum IgE in patients with minimal-change nephrotic syndrome.

Authors:  T Groshong; L Mendelson; S Mendoza; M Bazaral; R Hamburger; B Tune
Journal:  J Pediatr       Date:  1973-11       Impact factor: 4.406

7.  Detection of urinary interleukin-8 in glomerular diseases.

Authors:  T Wada; H Yokoyama; N Tomosugi; Y Hisada; S Ohta; T Naito; K Kobayashi; N Mukaida; K Matsushima
Journal:  Kidney Int       Date:  1994-08       Impact factor: 10.612

8.  Steroid-responsive nephrotic syndrome and allergy: immunological studies.

Authors:  S R Meadow; J K Sarsfield; D G Scott; S M Rajah
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

9.  Steroid-responsive and nephrotic syndrome and allergy: clinical studies.

Authors:  S R Meadow; J K Sarsfield
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

10.  A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

Authors:  S A Rosenberg; M T Lotze; L M Muul; A E Chang; F P Avis; S Leitman; W M Linehan; C N Robertson; R E Lee; J T Rubin
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

View more
  28 in total

1.  T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.

Authors:  Carlos Araya; Leila Diaz; Clive Wasserfall; Mark Atkinson; Wei Mu; Richard Johnson; Eduardo Garin
Journal:  Pediatr Nephrol       Date:  2009-06-03       Impact factor: 3.714

Review 2.  The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio Alvim Brito-Melo; Fábio Tadeu Lourenço Guimarães; Thiago Guimarães Rosa Carvalho; Elvis Cueva Mateo; Ana Cristina Simões e Silva
Journal:  Inflamm Res       Date:  2014-01       Impact factor: 4.575

Review 3.  Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.

Authors:  Kazunari Kaneko; Shoji Tsuji; Takahisa Kimata; Tetsuya Kitao; Sohsaku Yamanouchi; Shogo Kato
Journal:  World J Pediatr       Date:  2015-01-28       Impact factor: 2.764

Review 4.  Regulatory T cells and minimal change nephropathy: in the midst of a complex network.

Authors:  R Bertelli; A Bonanni; A Di Donato; M Cioni; P Ravani; G M Ghiggeri
Journal:  Clin Exp Immunol       Date:  2015-10-12       Impact factor: 4.330

5.  Correlation Between Idiopathic Nephrotic Syndrome and Atopy in Children - Short Review.

Authors:  Elena Camelia Berghea; Mihaela Balgradean; Ionela-Loredana Popa
Journal:  Maedica (Bucur)       Date:  2017-01

6.  Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study.

Authors:  A P Zbar; H Thomas; R W Wilkinson; M Wadhwa; K N Syrigos; E L Ross; P Dilger; T G Allen-Mersh; W A Kmiot; A A Epenetos; D Snary; W F Bodmer
Journal:  Int J Colorectal Dis       Date:  2005-04-30       Impact factor: 2.571

7.  Nephrotic syndrome and Hodgkin lymphoma in children. Report of two cases.

Authors:  A Pourtsidis; D Doganis; M Baka; M Varvoutsi; H Kosmidis
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

Review 8.  The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity.

Authors:  Asher D Schachter
Journal:  Pediatr Transplant       Date:  2004-08

9.  Association of IL-1beta, IL-1ra, and TNF-alpha gene polymorphisms in childhood nephrotic syndrome.

Authors:  Sung-Do Kim; Jae-Man Park; Il-Soo Kim; Kang-Duk Choi; Byung-Cheol Lee; Sang-Ho Lee; Seung-Jae Hong; Sheng-Yu Jin; Hee-Jae Lee; Mee-Suk Hong; Joo-Ho Chung; Tae-Won Lee; Chun-Gyoo Ihm; Byoung-Soo Cho
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714

10.  Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells.

Authors:  Lihua Bao; Mark Haas; Jeffrey Pippin; Ying Wang; Takashi Miwa; Anthony Chang; Andrew W Minto; Miglena Petkova; Guilin Qiao; Wen-Chao Song; Charles E Alpers; Jian Zhang; Stuart J Shankland; Richard J Quigg
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.